Updated Jul 16, 2026
Weill David has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.22M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | TMDX | TransMedics Group, Inc. | A — Grant or award | 2.9K | $0.00 | |
| 2026-03-06 | TMDX | TransMedics Group, Inc. | S — Open-market sale | 3.6K | $146.82 | $524K |
| 2026-03-06 | TMDX | TransMedics Group, Inc. | M — Option exercise | 3.6K | $14.20 | $51K |
| 2025-12-05 | TMDX | TransMedics Group, Inc. | S — Open-market sale | 5.0K | $138.64 | $693K |
| 2025-12-05 | TMDX | TransMedics Group, Inc. | M — Option exercise | 5.0K | $14.20 | $71K |
Weill David is a corporate insider — currently tracked as Insider of TransMedics Group, Inc. (TMDX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($1.22M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Weill David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.